Sangamo Therapeutics, Inc
What this means
- Bankruptcy or receivership reportedThe company reported a bankruptcy or receivership under Item 1.03 of Form 8-K on Sep 21, 2026. Creditors file claims with the bankruptcy court; the docket is on PACER.
- Securities removed from an exchangeA Form 25-NSE filed on Oct 7, 2026 removes a class of the company’s securities from listing (Removed from Nasdaq Stock Market). It can concern shares, warrants, notes or units — check the form for the class.
- Quarterly report lateOn Aug 17, 2026 the company filed Form NT 10-Q: it could not file its quarterly report on time. Rule 12b-25 gives an extra 15 calendar days for an annual report and 5 for a quarterly report. We have no later report from the company yet.
- Change of auditorOn Jul 1, 2026 the company reported a change of its independent accountant (Item 4.01). The 8-K must say whether there were disagreements with the former auditor.
- RestructuringOn Jun 23, 2026 the company committed to an exit or disposal plan with material costs (Item 2.05).
- Stockholders’ deficitAt the end of 2025 total liabilities exceeded total assets: stockholders’ equity was −$14.3M (XBRL data filed with the SEC).
- Net loss in 2025Net loss of $123M for the year (2024: −$97.9M).
- Revenue downRevenue fell from $57.8M in 2024 to $39.6M in 2025 (32% lower).
What to do next
- 8-K Item 1.03: what a bankruptcy filing means for suppliersguide
- NT 10-K: what a late-filing notice actually meansguide
- How to check a US company before you sign a contractguide
Guides from the Companies Daily newsroom, picked for what the register shows.
Financials from XBRL
| Calendar-year frame | 2025 | 2024 |
|---|---|---|
| Revenue | $39.6M | $57.8M |
| Net income (loss) | −$123M | −$97.9M |
| Total assets | $59.7M | $102M |
| Total liabilities | $74M | $78.9M |
| Stockholders’ equity | −$14.3M | $22.8M |
| Cash and equivalents | $20.9M | $41.9M |
From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.
- Name as filed
- SANGAMO THERAPEUTICS, INC
Formerly: Sangamo Biosciences Inc - CIK
- 0001001233
- Tickers
- SGMOQ
- Kind of filer
- SEC-reporting company
Non-accelerated filer; Smaller reporting company - Status
- Filing with the SEC — securities delisted
- State of incorporation
- Delaware
- Business address
- Richmond, California
- Industry (SIC)
- 2836 · Biological products, (no diagnostic substances)
Industry: D · Manufacturing → - Fiscal year ends
- December 31
- Last annual report
- 10-K for the period ended Dec 31, 2025
- Last quarterly report
- 10-Q for the quarter ended Mar 31, 2026
- Bankruptcy reported
- Not in our data
- Last edition event
- Oct 7, 2026
Filing history
Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.
- Form 25-NSE · filed Oct 7, 2026 · filing
- Form 8-K · items 1.03, 2.01, 9.01 · filed Sep 21, 2026 · filing
- Form 8-K · items 1.03, 2.01, 9.01 · filed Sep 21, 2026 · filing
- Form 8-K · items 1.03, 2.01, 7.01, 9.01 · filed Sep 8, 2026 · filing
- Form 8-K · items 1.03, 2.01, 7.01, 9.01 · filed Sep 8, 2026 · filing
- Form 8-K · items 1.01, 1.03, 9.01 · filed Aug 28, 2026 · filing
- Form NT 10-Q · filed Aug 17, 2026 · filing
- Form 8-K · items 1.03, 3.01 · filed Jul 20, 2026 · filing
- Form 8-K · items 1.03, 3.01 · filed Jul 20, 2026 · filing
- Form 8-K · items 4.01, 8.01, 9.01 · filed Jul 1, 2026 · filing
- Form 8-K · items 1.01, 1.03, 2.03, 2.05 · filed Jun 23, 2026 · filing
- Form 8-K · items 1.01, 1.03, 2.03, 2.05 · filed Jun 23, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed May 14, 2026 · filing
- Form 10-Q · filed May 14, 2026 · filing
- Form 8-K · items 3.01 · filed Apr 29, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 30, 2026 · filing
- Form 10-K · filed Mar 30, 2026 · filing
- Form 8-K · items 2.02, 5.02 · filed Feb 3, 2026 · filing
- Form 8-K · items 2.02, 5.02 · filed Feb 3, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 6, 2025 · filing
- Form 10-Q · filed Nov 6, 2025 · filing
- Form 8-K · items 3.01 · filed Oct 29, 2025 · filing
- Form 8-K · items 5.02 · filed Sep 30, 2025 · filing
- Form 8-K · items 5.02 · filed Sep 11, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 7, 2025 · filing
- Form 10-Q · filed Aug 7, 2025 · filing
- Form 8-K · items 5.02, 5.07, 9.01 · filed Jun 16, 2025 · filing
- Form 10-Q · filed May 12, 2025 · filing
- Form 8-K · items 3.01 · filed May 6, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 17, 2025 · filing
- Form 10-K · filed Mar 17, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 12, 2024 · filing
- Form 10-Q · filed Nov 12, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 6, 2024 · filing
- Form 10-Q · filed Aug 6, 2024 · filing
- Form 8-K · items 5.02, 5.03, 5.07, 9.01 · filed Jun 5, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed May 9, 2024 · filing
- Form 10-Q · filed May 9, 2024 · filing
- Form 8-K · items 3.01 · filed Apr 30, 2024 · filing
- Form 10-K · filed Mar 13, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 13, 2024 · filing
- Form 8-K · items 5.02 · filed Jan 19, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 1, 2023 · filing
- Form 10-Q · filed Nov 1, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 8, 2023 · filing
- Form 10-Q · filed Aug 8, 2023 · filing
- Form 8-K · items 5.02, 5.03, 5.07 · filed Jun 2, 2023 · filing
- Form 10-Q · filed May 8, 2023 · filing
- Form 8-K · items 2.02, 2.05, 5.02, 9.01 · filed Apr 26, 2023 · filing
- Form 8-K · items 2.02, 2.05, 5.02, 9.01 · filed Apr 26, 2023 · filing
- Form 8-K · items 2.02, 2.05, 5.02, 9.01 · filed Apr 26, 2023 · filing
- Form 10-K · filed Feb 23, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Feb 22, 2023 · filing